慢性肾脏病与肾移植中的衰弱
本文综述了衰弱在慢性肾脏病(CKD)患者中的定义、对健康结局的影响、发生机制及抗衰弱干预措施。衰弱是CKD患者常见的临床综合征,与跌倒、生活质量下降、住院和死亡等多种不良结局相关,但现有衰弱定义在CKD中仍有局限,抗衰弱策略的有效性尚需进一步研究。
要点
- 衰弱是CKD患者风险分层的潜在工具,与跌倒、住院和死亡等不良结局相关。
- CKD中衰弱的机制涉及衰老生物学和生理失调等多因素。
- 运动或衰老细胞清除等抗衰弱干预在CKD中前景可期但证据有限。
核心结论
- 衰弱是CKD患者中常见的临床综合征,与多种不良健康结局相关,但现有衰弱定义在CKD中仍有局限,抗衰弱干预是否改善肾脏及整体健康结局尚需进一步研究。
研究设计与样本
- 本文为综述,检索范围未在摘要中明确报告。
主要发现
- 衰弱在CKD患者中常见,并与跌倒、生活质量下降、住院和死亡等不良结局相关。
- CKD中衰弱的发生涉及衰老生物学机制和生理失调等多种病理因素。
- 运动或衰老细胞清除等抗衰弱干预在CKD患者中已进行测试,结果 promising,但需进一步研究确认其是否改善肾脏及整体健康结局。
临床怎么用
- 对CKD患者可考虑评估衰弱以进行风险分层,但需注意现有衰弱定义在CKD中的局限性。
局限性
- 现有衰弱定义在CKD中存在局限性,有效抗衰弱策略在CKD中仍面临挑战。
- 抗衰弱干预是否改善肾脏和整体健康结局尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The population is aging. Although older adults have higher rates of comorbidities and adverse health events, they represent a heterogeneous group with different health trajectories. Frailty, a clinical syndrome of decreased physiological reserve and increased susceptibility to illness and death, has emerged as a potential risk stratification tool in older patients with chronic kidney disease (CKD). Frailty is commonly observed in patients with CKD and associated with numerous adverse outcomes, including falls, decreased quality of life, hospitalizations, and death. Multiple pathologic factors contribute to the development of frailty in patients with CKD, including biological mechanisms of aging and physiological dysregulation. Current interventions to reduce frailty are promising, but additional investigations are needed to determine whether optimizing frailty measures improves renal and overall health outcomes. This review of frailty in CKD examines frailty definitions, the impact of frailty on health outcomes across the CKD spectrum, mechanisms of frailty, and antifrailty interventions (e.g., exercise or senescent cell clearance) tested in CKD patients. In addition, existing knowledge gaps, limitations of current frailty definitions in CKD, and challenges surrounding effective antifrailty strategies in CKD are considered.
引用
- Lorenz EC, Kennedy CC, Rule AD, et al. Frailty in CKD and Transplantation. Kidney Int Rep. 2021. PMID: 34514190. doi:10.1016/j.ekir.2021.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。